Creative Medical Technology Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Creative Medical Technology Holdings generated cash of -$8,027,884, which is less than the previous year. Cash used in financing activities reached the amount of -$270,952 last year. Net change in cash is therefore -$4,853,652.
Cash Flow
| 2014 | -17.32K | 0 | 17.9K |
|---|---|---|---|
| 2015 | -14.63K | 0 | 13.9K |
| 2016 | -445.23K | -10K | 677K |
| 2017 | -889.62K | 0 | 681.45K |
| 2018 | -1.05M | 0 | 1.34M |
| 2019 | -1.21M | 0 | 997.68K |
| 2020 | -434.55K | -250K | 693.92K |
| 2021 | -2.21M | 0 | 12.84M |
| 2022 | -7.79M | -10.07M | 15.47M |
| 2023 | -8.02M | 3.44M | -270.95K |
CELZ Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 8.32M | 10.72M | 98.01K | 88.64K | 304.05K | 13.69K | 221.86K | 100 | 954 | 374 |
Operating activities | ||||||||||
Net income | -5.28M | -10.14M | 19.21M | -36.32M | -8.48M | -13.65M | -2.65M | -766.07K | -30.76K | -28.01K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 94.58K | 92.08K | 92.08K | 66.79K | 26.95K | 21.14K | 15.99K | 9.35K | 0 | 0 |
Stock-based compensation expense | 36.64K | 68.74K | 595.38K | 170.32K | 0 | 0 | 144.16K | 2.56K | 0 | 0 |
| Deferred income tax benefit | 36.64K | 68.74K | 595.38K | 170.32K | 0 | 0 | 144.16K | 2.56K | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 2.48K | -2.48K | 5.6K | 4K | -4.79K | -4.80K | 0 | 0 | 0 |
Inventories | 3.6K | 672 | -10.86K | 0 | 0 | 4.19M | 2.40M | 0 | 0 | 0 |
Accounts payable | -2.95M | 2.50M | 410.96K | 30.11K | -11.05K | 94.76K | 171.18K | 22.60K | 6.89K | 2.10K |
Cash generated by operating activities | -8.02M | -7.79M | -2.21M | -434.55K | -1.21M | -1.05M | -889.62K | -445.23K | -14.63K | -17.32K |
Investing activities | ||||||||||
Purchases Of Investments | -22.85M | -10.07M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | -250K | 0 | 0 | 0 | -10K | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 3.44M | -10.07M | 0 | -250K | 0 | 0 | 0 | -10K | 0 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 0 | 15.47M | 14.75M | 0 | 0 | 0 | 100K | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -270.95K | 0 | -196.75K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -5.95M | -17K | 997.68K | -462.29K | 573.25K | 0 | 13.9K | 0 |
Cash used in financing activities | -270.95K | 15.47M | 12.84M | 693.92K | 997.68K | 1.34M | 681.45K | 677K | 13.9K | 17.9K |
Net Change In Cash | -4.85M | -2.40M | 10.62M | 9.36K | -215.40K | 290.35K | -208.17K | 221.76K | -738 | 580 |
Cash at end of period | 3.46M | 8.32M | 10.72M | 98.01K | 88.64K | 304.05K | 13.69K | 221.86K | 216 | 954 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |